USRM Demonstrates 99% Reduction in Severity of Psoriasis Utilizing Autologous Stem Cells
KTRE,
Information contained on this page is provided by an independent third-party content provider.
Information contained on this page is provided by an independent third-party content provider.
Information contained on this page is provided by an independent third-party content provider.
Autoimmune Skin Condition Affects More Than 7 million in the United States SUNRISE, Fla., March 21, 2018 /PRNewswire/ -- U.S.
PR Newswire SUNRISE, Fla., March 21, 2018 SUNRISE, Fla., March 21, 2018 /PRNewswire/ -- U.S.
/PRNewswire/ -- U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell…
/PRNewswire/ --. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel…
SUNRISE, Fla., March 21, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary…
Autoimmune Skin Condition Affects More Than 7 million in the United States SUNRISE, Fla., March 21, 2018 /PRNewswire/ -- U.S.